Bayer stock trades at EUR 43.88 with volume 85.7 percent below average

Published on 10/12/2026 at 13:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Bayer stock is 0.25 percent above the October 9 Xetra close of EUR 43.77. It trades at EUR 43.88 on October 12, 2026.

Key points in brief

Bayer stock traded at EUR 43.88 at Lang & Schwarz on October 12, 2026, up 0.25 percent versus the October 9 Xetra close of EUR 43.77.
Trading volume was 296,302 shares, 85.7 percent below the 2,072,485-share average.
The stock stood 18.62 percent below its 52-week high of EUR 53.92 and had a market capitalization of EUR 43.1 billion.
JPMorgan kept its Overweight rating and EUR 61.00 target on October 1, 2026, while warning that third-quarter expectations could be high.

Bauhaus-Stil Poster mit geometrischen Formen, Kreisen und dem Schriftzug PHARMA — Bayer AG (DE000BAY0017): Bauhaus-Poster mit geometrischen Formen, kräftigen Farben und dem großen Schriftzug PHARMA, Illustration mit AI erstellt.

Bayer stock (ISIN DE000BAY0017) was trading at EUR 43.88 at Lang & Schwarz on October 12, 2026 at 1:30 p.m. CEST, up 0.25 percent versus the Xetra close of October 9, 2026 at EUR 43.77. Trading volume stood at 296,302 shares, which is 85.70 percent below the 2,072,485-share average.

Volume stays below average

The intraday quote places Bayer at EUR 43.88, with a bid of EUR 43.85 and an ask of EUR 43.90. The gap between the current price and the 52-week high of EUR 53.92 is 18.62 percent, while the 52-week low stands at EUR 25.78.

The stock's market capitalization is EUR 43.1 billion. Bayer's price-to-earnings ratio is minus 24.94, a valuation measure that reflects the company's earnings profile rather than a simple comparison with profitable peers.

Analyst target remains EUR 61

According to FinanzNachrichten on October 1, 2026, JPMorgan kept its Overweight rating and EUR 61.00 price target for Bayer. The note said early expectations for the third quarter could be too high because of timing effects in the agricultural business, while full-year estimates were expected to remain broadly unchanged.

At EUR 43.88, the JPMorgan target lies 38.99 percent above the Lang & Schwarz price. The target therefore provides a distinct valuation reference, while the current quote remains below the annual high and the trading volume is well below its average.

Comparison with peers

Bayer: plus 0.25 percent, P/E minus 24.94, market capitalization EUR 43.1 billion
BASF (Xetra, EUR): minus 0.82 percent, P/E 7.71, market capitalization EUR 44.2 billion
Merck KGaA (Xetra, EUR): plus 0.40 percent, P/E 25.39, market capitalization EUR 60.1 billion

Next report date approaches

FinanzNachrichten cited November 3, 2026 as the date for Bayer's third-quarter report. That date gives the market a defined event ahead, while the current price remains 18.62 percent below the 52-week high.

Price remains below yearly high

Bayer was trading at EUR 43.88 at Lang & Schwarz on October 12, 2026 at 1:30 p.m. CEST, up 0.25 percent versus the Xetra close of October 9, 2026 at EUR 43.77. The further course of trading is shown by the continuously updated real-time quote of Bayer stock.